Two years after stepping down amidst house arrest, Frank Zhang is back as Legend chair
Nearly two years after his arrest as part of a smuggling investigation, Frank Zhang is back in the game.
Zhang, the founder and former CEO of GenScript Biotech, has been appointed as a director of Legend Biotech, GenScript’s CAR-T subsidiary, which he founded in 2014. He previously served as its CEO but decided to step down from the role during the ongoing investigation. Charges against Zhang were dropped earlier this year, and he had previously returned to a non-executive director role at GenScript.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 147,700+ biopharma pros reading Endpoints daily — and it's free.